Haemonetics (HAE) Curent Deferred Tax Liability (2010 - 2012)
Haemonetics' (HAE) quarterly Curent Deferred Tax Liability came in at $250000.0 in Q4 2012, up 233.33% year-on-year from $75000.0 in Q4 2011, and up 11.11% quarter-over-quarter from $225000.0 in Q3 2012.
Haemonetics (HAE) Curent Deferred Tax Liability (2010 - 2012) Analysis & Trends
Haemonetics' Curent Deferred Tax Liability history runs 3 years deep, the most recent figure standing at $250000.0 for Q4 2012.
- On a quarterly basis, Curent Deferred Tax Liability rose 233.33% year-over-year to $250000.0 in Q4 2012; TTM through Dec 2012 was $250000.0, a 233.33% increase from a year earlier, with the FY2012 full-year figure at $64000.0, down 40.19% from the prior year.
- Curent Deferred Tax Liability climbed to $250000.0 in Q4 2012 per HAE's latest filing, from $225000.0 in the prior quarter.
- Across five years, Curent Deferred Tax Liability topped out at $1.2 million in Q1 2011 and bottomed at $64000.0 in Q1 2012.
- The 3-year median for Curent Deferred Tax Liability is $199000.0 (2010), against an average of $353666.7.
- Across the five-year window, Curent Deferred Tax Liability slumped 93.63% in 2011 and surged 233.33% in 2012, its largest moves.
- Year by year, Curent Deferred Tax Liability stood at $1.1 million in 2010, then plunged by 93.37% to $75000.0 in 2011, then jumped by 233.33% to $250000.0 in 2012.
- Per Business Quant, the three latest HAE Curent Deferred Tax Liability figures stand at $250000.0 (Q4 2012), $225000.0 (Q3 2012), and $297000.0 (Q2 2012).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Curent Deferred Tax (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | - |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | - |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | - |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | - |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | - |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | - |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | - |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | - |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Haemonetics | 3.50 Bn | 3.26 Bn | 198.21 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 29, 2012 | 250,000.00 |
| Dec 29, 2012 | 250,000.00 |
| Sep 29, 2012 | 225,000.00 |
| Sep 29, 2012 | 225,000.00 |
| Jun 30, 2012 | 297,000.00 |
| Jun 30, 2012 | 297,000.00 |
| Mar 31, 2012 | 64,000.00 |
| Mar 31, 2012 | 64,000.00 |
| Dec 31, 2011 | 75,000.00 |
| Dec 31, 2011 | 75,000.00 |
| Oct 1, 2011 | 123,000.00 |
| Oct 1, 2011 | 123,000.00 |
| Jul 2, 2011 | 554,000.00 |
| Jul 2, 2011 | 554,000.00 |
| Apr 2, 2011 | 107,000.00 |
| Apr 2, 2011 | 107,000.00 |
| Jan 1, 2011 | 1.18 Mn |
| Jan 1, 2011 | 1.18 Mn |
| Oct 2, 2010 | 1.13 Mn |
| Oct 2, 2010 | 1.13 Mn |